Allison Fitzgerald, MD, PhD/X
Dec 19, 2025, 11:34
Arterial or Atypical Clots? Think APLS, PNH, and MPN
Allison Fitzgerald, Heme/Onc Fellow at Dana-Farber, posted on X:
”Today I learned that while clots in veins can be caused by all sorts of things, clots in arteries are usually caused by cancer or anti-phospholipid syndrome (APLS).
Adding paroxysmal nocturnal hemoglobinuria and myeloproliferative neoplasms (which is a subtype of cancer, but more specific, I suppose) to this list.
So clots in arterial or weird venous places:
– APLS
– PNH
– MPN
– HIT
– hyperhomocysteinemia”
Stay updated with Hemostasis Today.
Allison Fitzgerald
Antiphospholipid Syndrome
APLS
APS
Arterial thrombosis
Blood Clot
Cancer Associated Thrombosis
Dana-Farber
Health
Hematology
Hemostasis
Hemostasis Today
heparin-induced thrombocytopenia
HIT
Hyperhomocysteinemia
Medicine
MPN
myeloproliferative neoplasms
paroxysmal nocturnal hemoglobinuria
PNH
thrombosis
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn RuksakulpiwatÖ‰ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin